Submit your email to push it up the queue
Pharmscript, L.L.C., headquartered in the United States, is a leading provider of pharmacy services tailored for long-term care facilities. Founded in 2015, the company has rapidly expanded its operations across multiple states, establishing a strong presence in the healthcare industry. Pharmscript is renowned for its innovative medication management solutions, which streamline pharmacy operations and enhance patient care. The company offers a range of core services, including customised medication packaging and comprehensive pharmacy consulting, setting it apart from competitors. With a commitment to quality and efficiency, Pharmscript has achieved significant milestones, including recognition for its exceptional service delivery in the long-term care sector. As a trusted partner for healthcare providers, Pharmscript continues to strengthen its market position through a focus on patient-centric solutions and operational excellence.
How does Pharmscript, L.L.C.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Pharmscript, L.L.C.'s score of 72 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmscript, L.L.C., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of UnitedHealth Group Incorporated, which influences its climate commitments and initiatives. While Pharmscript has not set its own reduction targets, it inherits sustainability goals and initiatives from its parent company, UnitedHealth Group. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded down from UnitedHealth Group at a corporate family level. Pharmscript's climate strategy aligns with broader industry standards, focusing on reducing carbon footprints and enhancing sustainability practices. However, specific reduction targets or achievements have not been disclosed at this time. The company is expected to follow the climate commitments established by its parent organisation, contributing to a collective effort towards climate action within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmscript, L.L.C. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.